Charles van Es - Mar 10, 2023 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Signature
By: Yolanda Goettsch, Attorney-in-Fact For: Charles Van Es
Stock symbol
COCO
Transactions as of
Mar 10, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 09:36 PM
Previous filing
Dec 1, 2022
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCO Common Stock Award $0 +5.91K +6.77% $0.00 93.3K Mar 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCO Non-Qualified Stock Option (right to buy) Award $0 +14.2K $0.00 14.2K Mar 10, 2023 Common Stock 14.2K $16.91 Direct F2
holding COCO Non-Qualified Stock Option (right to buy) 130K Mar 10, 2023 Common Stock 130K $10.18 Direct F3
holding COCO Non-Qualified Stock Option (right to buy) 114K Mar 10, 2023 Common Stock 114K $10.18 Direct F4
holding COCO Non-Qualified Stock Option (right to buy) 27.3K Mar 10, 2023 Common Stock 27.3K $10.18 Direct F5
holding COCO Non-Qualified Stock Option (right to buy) 58K Mar 10, 2023 Common Stock 58K $15.00 Direct F6
holding COCO Non-Qualified Stock Option (right to buy) 43K Mar 10, 2023 Common Stock 43K $15.36 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
F2 The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
F3 The stock option is fully vested and currently exercisable.
F4 The stock option is fully vested and currently exercisable with respect to 56,875 underlying shares. The remainder will vest on February 10, 2024.
F5 The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
F6 The stock option vests in four equal annual installments beginning on November 27, 2022.
F7 The stock option vests in three equal annual installments beginning on August 15, 2025.